L3045
β-Lactamase from Pseudomonas fluorescens
lyophilized powder, recombinant, expressed in E. coli
Product Name
β-Lactamase from Pseudomonas fluorescens, lyophilized powder, recombinant, expressed in E. coli
recombinant
expressed in E. coli
form
lyophilized powder
enzyme activity
7.5-15 units/mg solid
shipped in
wet ice
storage temp.
2-8°C
Quality Level
Other Notes
One unit will hydrolyze 1.0 μmole of benzylpenicillin per minute at pH 7.0 at 25 °C
Physical form
Lyophilized powder containing potassium phosphate and sodium bicarbonate
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Molecular characterization of metallo-β-lactamase-producing Pseudomonas aeruginosa in a Czech hospital (2009-2011).
C C Papagiannitsis et al.
Journal of medical microbiology, 62(Pt 6), 945-947 (2013-03-16)
Jiri Klimes et al.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 44(1), 173-175 (2013-03-20)
Only a few reports exist on the occurrence of resistant bacteria in zoo animals. Therefore, an isolation of multiresistant Escherichia coli from the lungs of a captive South American tapir (Tapirus terrestris) lead to its characterization and further investigation of
A A Alsultan et al.
Journal of medical microbiology, 62(Pt 6), 885-888 (2013-03-23)
Carbapenem-resistant Acinetobacter baumannii is becoming increasingly prevalent in patients with diabetes mellitus in the Middle East. We examined the relationship of these bacteria and their resistance mechanisms to the diabetic disease status of patients in Saudi Arabia. Susceptibilities of 271
Mayuri Trivedi et al.
The Journal of the Association of Physicians of India, 60, 28-30 (2013-02-15)
In India where the prevalence of extended spectrum beta lactamase (ESBL) producing organisms among gram negative organisms is 60-70% and Ertapenem was unavailable at the beginning of this study, exclusive use of Group 2 Carbapenems (Imipenem and Meropenem) for treatment
Indian public health leaders move to reduce antimicrobial resistance.
Mike Mitka
JAMA, 309(6), 531-532 (2013-02-14)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service